Financials data is unavailable for this security.
View more
Year on year Cowealth Medical China Co Ltd 's revenues fell -14.62% from 1.28bn to 1.09bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 82.72m to 47.19m, a -42.96% decrease.
| Gross margin | 19.62% |
|---|---|
| Net profit margin | 3.13% |
| Operating margin | 4.10% |
| Return on assets | 2.01% |
|---|---|
| Return on equity | 2.54% |
| Return on investment | 2.59% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Cowealth Medical China Co Ltd fell by 119.63m. However, the company earned 11.28m from its operations for a Cash Flow Margin of 1.03%. In addition the company used 51.65m on investing activities and also paid 78.87m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 2.93 |
|---|---|
| Tangible book value per share | 2.91 |
More ▼
Balance sheet in CNYView more
| Current ratio | 4.32 |
|---|---|
| Quick ratio | 3.65 |
| Total debt/total equity | 0.0907 |
|---|---|
| Total debt/total capital | 0.0829 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -60.00% and -42.96%, respectively. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 80.51% |
| EPS growth(5 years) | -6.75 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -59.11 |
More ▼
